IPRATROPIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ipratropium, and when can generic versions of Ipratropium launch?
Ipratropium is a drug marketed by Armstrong Pharms, Actavis Mid Atlantic, Apotex Inc, Bausch, Landela Pharm, Luoxin Aurovitas, Nephron, Pharmobedient, Ritedose Corp, Roxane, Sun Pharm, Teva Pharms Usa, Watson Labs, Zennova, Amneal, Aurobindo Pharma Usa, Hikma, Lupin, and Rubicon Research. and is included in twenty-eight NDAs.
The generic ingredient in IPRATROPIUM is ipratropium bromide. There are eight drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the ipratropium bromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ipratropium
A generic version of IPRATROPIUM was approved as ipratropium bromide by RITEDOSE CORP on January 26th, 2001.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for IPRATROPIUM?
- What are the global sales for IPRATROPIUM?
- What is Average Wholesale Price for IPRATROPIUM?
Summary for IPRATROPIUM
| US Patents: | 0 |
| Applicants: | 19 |
| NDAs: | 28 |
| Drug Prices: | Drug price information for IPRATROPIUM |
| Drug Sales Revenues: | Drug sales revenues for IPRATROPIUM |
| DailyMed Link: | IPRATROPIUM at DailyMed |
US Patents and Regulatory Information for IPRATROPIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rubicon Research | IPRATROPIUM BROMIDE | ipratropium bromide | SPRAY, METERED;NASAL | 219221-001 | Nov 15, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Armstrong Pharms | IPRATROPIUM BROMIDE | ipratropium bromide | AEROSOL, METERED;INHALATION | 217953-001 | Feb 23, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Apotex Inc | IPRATROPIUM BROMIDE | ipratropium bromide | SPRAY, METERED;NASAL | 076155-001 | Apr 18, 2003 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hikma | IPRATROPIUM BROMIDE | ipratropium bromide | SPRAY, METERED;NASAL | 076598-001 | Nov 5, 2003 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
